Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment.
Saved in:
| Title: | Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment. |
|---|---|
| Authors: | Palumbo JM; Zynerba Pharmaceuticals Inc., Devon, PA, USA., Thomas BF; Empirical Pharmaceutical Services, LLC, Manteo, NC, USA., Budimirovic D; Departments of Psychiatry and Neurogenetics, Fragile X Clinic, Kennedy Krieger Institute, Baltimore, MD, USA.; Department of Psychiatry & Behavioral Sciences-Child Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, USA., Siegel S; Department of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Tassone F; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California-Davis Medical Center, Sacramento, CA, USA.; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California-Davis, Sacramento, CA, USA., Hagerman R; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California-Davis Medical Center, Sacramento, CA, USA.; Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA, USA., Faulk C; Department of Animal Science, University of Minnesota, St. Paul, MN, USA., O'Quinn S; Zynerba Pharmaceuticals Inc., Devon, PA, USA. Oquinns@Zynerba.com., Sebree T; Zynerba Pharmaceuticals Inc., Devon, PA, USA. |
| Source: | Journal of neurodevelopmental disorders [J Neurodev Disord] 2023 Jan 09; Vol. 15 (1), pp. 1. Date of Electronic Publication: 2023 Jan 09. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101483832 Publication Model: Electronic Cited Medium: Internet ISSN: 1866-1955 (Electronic) Linking ISSN: 18661947 NLM ISO Abbreviation: J Neurodev Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36624400 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Palumbo+JM%22">Palumbo JM</searchLink>; Zynerba Pharmaceuticals Inc., Devon, PA, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+BF%22">Thomas BF</searchLink>; Empirical Pharmaceutical Services, LLC, Manteo, NC, USA.<br /><searchLink fieldCode="AU" term="%22Budimirovic+D%22">Budimirovic D</searchLink>; Departments of Psychiatry and Neurogenetics, Fragile X Clinic, Kennedy Krieger Institute, Baltimore, MD, USA.; Department of Psychiatry & Behavioral Sciences-Child Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Siegel+S%22">Siegel S</searchLink>; Department of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tassone+F%22">Tassone F</searchLink>; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California-Davis Medical Center, Sacramento, CA, USA.; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California-Davis, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hagerman+R%22">Hagerman R</searchLink>; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California-Davis Medical Center, Sacramento, CA, USA.; Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Faulk+C%22">Faulk C</searchLink>; Department of Animal Science, University of Minnesota, St. Paul, MN, USA.<br /><searchLink fieldCode="AU" term="%22O'Quinn+S%22">O'Quinn S</searchLink>; Zynerba Pharmaceuticals Inc., Devon, PA, USA. Oquinns@Zynerba.com.<br /><searchLink fieldCode="AU" term="%22Sebree+T%22">Sebree T</searchLink>; Zynerba Pharmaceuticals Inc., Devon, PA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101483832%22">Journal of neurodevelopmental disorders</searchLink> [J Neurodev Disord] 2023 Jan 09; Vol. 15 (1), pp. 1. <i>Date of Electronic Publication: </i>2023 Jan 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101483832 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1866-1955 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218661947%22">18661947 </searchLink><i>NLM ISO Abbreviation: </i>J Neurodev Disord <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36624400 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s11689-023-09475-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Palumbo JM – PersonEntity: Name: NameFull: Thomas BF – PersonEntity: Name: NameFull: Budimirovic D – PersonEntity: Name: NameFull: Siegel S – PersonEntity: Name: NameFull: Tassone F – PersonEntity: Name: NameFull: Hagerman R – PersonEntity: Name: NameFull: Faulk C – PersonEntity: Name: NameFull: O'Quinn S – PersonEntity: Name: NameFull: Sebree T IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 01 Text: 2023 Jan 09 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1866-1955 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Journal of neurodevelopmental disorders Type: main |
| ResultId | 1 |